Dimerix Ltd (DXB) - Cash Flow Conversion Efficiency

Latest as of June 2025: 3.087x

Based on the latest financial reports, Dimerix Ltd (DXB) has a cash flow conversion efficiency ratio of 3.087x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$41.30 Million ≈ $29.22 Million USD) by net assets (AU$13.38 Million ≈ $9.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Dimerix Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Dimerix Ltd - Cash Flow Conversion Efficiency Trend (1992–2025)

This chart illustrates how Dimerix Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dimerix Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dimerix Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Altenergy Acquisition Corp
NASDAQ:AEAE
0.017x
XBiotech Inc
NASDAQ:XBIT
-0.164x
Vortex Consolidated Bhd
KLSE:0060
-0.013x
Optex Systems Holdings, Inc. Common Stock
NASDAQ:OPXS
-0.047x
Technology & Telecommunication
NASDAQ:TETE
0.010x
Lu Hai Holding Corp
TW:2115
0.002x
Tecnotree Oyj
HE:TEM1V
0.035x
Fortune Parts Industry Public Company Limited
BK:FPI
0.028x

Annual Cash Flow Conversion Efficiency for Dimerix Ltd (1992–2025)

The table below shows the annual cash flow conversion efficiency of Dimerix Ltd from 1992 to 2025. For the full company profile with market capitalisation and key ratios, see DXB company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$13.38 Million
≈ $9.47 Million
AU$39.05 Million
≈ $27.63 Million
2.919x +857.87%
2024-06-30 AU$18.19 Million
≈ $12.87 Million
AU$-7.00 Million
≈ $-4.96 Million
-0.385x +81.96%
2023-06-30 AU$5.96 Million
≈ $4.22 Million
AU$-12.73 Million
≈ $-9.01 Million
-2.135x -129.17%
2022-06-30 AU$14.42 Million
≈ $10.20 Million
AU$-13.44 Million
≈ $-9.51 Million
-0.932x +78.83%
2021-06-30 AU$1.47 Million
≈ $1.04 Million
AU$-6.46 Million
≈ $-4.57 Million
-4.401x -623.25%
2020-06-30 AU$7.76 Million
≈ $5.49 Million
AU$-4.72 Million
≈ $-3.34 Million
-0.608x +7.03%
2019-06-30 AU$4.20 Million
≈ $2.97 Million
AU$-2.75 Million
≈ $-1.95 Million
-0.655x -39.16%
2018-06-30 AU$6.86 Million
≈ $4.85 Million
AU$-3.23 Million
≈ $-2.28 Million
-0.470x +33.66%
2017-06-30 AU$2.63 Million
≈ $1.86 Million
AU$-1.86 Million
≈ $-1.32 Million
-0.709x -15.29%
2016-06-30 AU$2.24 Million
≈ $1.59 Million
AU$-1.38 Million
≈ $-975.82K
-0.615x -205.76%
2015-06-30 AU$2.78 Million
≈ $1.96 Million
AU$-558.55K
≈ $-395.21K
-0.201x +58.31%
2014-06-30 AU$1.18 Million
≈ $834.33K
AU$-568.88K
≈ $-402.52K
-0.482x +97.30%
2014-04-30 AU$31.22K
≈ $22.09K
AU$-558.55K
≈ $-395.21K
-17.893x -9885.60%
2013-06-30 AU$1.71 Million
≈ $1.21 Million
AU$-305.90K
≈ $-216.44K
-0.179x +9.01%
2012-06-30 AU$1.18 Million
≈ $834.76K
AU$-232.33K
≈ $-164.39K
-0.197x +5.57%
2011-06-30 AU$1.57 Million
≈ $1.11 Million
AU$-326.54K
≈ $-231.04K
-0.209x +12.93%
2010-06-30 AU$1.56 Million
≈ $1.10 Million
AU$-373.67K
≈ $-264.39K
-0.240x +95.32%
2009-06-30 AU$341.98K
≈ $241.97K
AU$-1.75 Million
≈ $-1.24 Million
-5.113x -114.66%
2008-06-30 AU$1.01 Million
≈ $713.34K
AU$-2.40 Million
≈ $-1.70 Million
-2.382x -103.42%
2007-06-30 AU$1.41 Million
≈ $1.00 Million
AU$-1.66 Million
≈ $-1.17 Million
-1.171x -56.68%
2006-06-30 AU$2.69 Million
≈ $1.91 Million
AU$-2.01 Million
≈ $-1.42 Million
-0.747x -405.76%
2005-06-30 AU$10.28 Million
≈ $7.27 Million
AU$-1.52 Million
≈ $-1.07 Million
-0.148x -102.79%
2004-06-30 AU$-170.38K
≈ $-120.55K
AU$-902.37K
≈ $-638.48K
5.296x +422.93%
2003-06-30 AU$-565.02K
≈ $-399.79K
AU$-572.26K
≈ $-404.91K
1.013x +147.45%
2002-06-30 AU$282.89K
≈ $200.16K
AU$-603.82K
≈ $-427.24K
-2.135x -1434.07%
2001-06-30 AU$640.43K
≈ $453.14K
AU$102.47K
≈ $72.50K
0.160x +74.25%
2000-06-30 AU$5.24 Million
≈ $3.71 Million
AU$481.16K
≈ $340.45K
0.092x -48.60%
1999-06-30 AU$5.77 Million
≈ $4.08 Million
AU$1.03 Million
≈ $729.49K
0.179x +303.76%
1997-06-30 AU$1.96 Million
≈ $1.39 Million
AU$-171.60K
≈ $-121.42K
-0.088x -29.69%
1996-06-30 AU$1.85 Million
≈ $1.31 Million
AU$-125.03K
≈ $-88.47K
-0.068x +5.26%
1995-06-30 AU$1.72 Million
≈ $1.22 Million
AU$-123.00K
≈ $-87.03K
-0.071x -16.09%
1994-06-30 AU$1.74 Million
≈ $1.23 Million
AU$-107.00K
≈ $-75.71K
-0.061x -147.59%
1993-06-30 AU$1.41 Million
≈ $997.66K
AU$-35.00K
≈ $-24.76K
-0.025x -299.35%
1992-06-30 AU$1.04 Million
≈ $738.70K
AU$13.00K
≈ $9.20K
0.012x --

About Dimerix Ltd

AU:DXB Australia Biotechnology
Market Cap
$72.22 Million
AU$102.07 Million AUD
Market Cap Rank
#20434 Global
#690 in Australia
Share Price
AU$0.17
Change (1 day)
-2.86%
52-Week Range
AU$0.17 - AU$0.63
All Time High
AU$0.77
About

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is… Read more